Iran: Dỡ bỏ trừng phạt là vấn đề quan trọng nhất của đàm phán hạt nhân

Ngày 31/1, Iran cho biết vẫn còn những bất đồng với Mỹ liên quan đến các vấn đề như dỡ bỏ lệnh trừng phạt hay việc đạt được các bảo đảm tại cuộc đàm phán ở Vienna (Áo) liên quan tới khôi phục thỏa thuận hạt nhân năm 2015.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh